TD Waterhouse Canada »

Black Diamond Therapeutics shares owned by TD Waterhouse Canada

Quarter-by-quarter ownership of Black Diamond Therapeutics (BDTX) shares owned by TD Waterhouse Canada from 13F filings

Historical chart of TD Waterhouse Canada investment in Black Diamond Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Black Diamond Therapeutics held by TD Waterhouse Canada consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Black Diamond Therapeutics by TD Waterhouse Canada

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.1k 300 3.72
2025-06-30 $743 300 2.48

More positions owned by TD Waterhouse Canada

Rbc Cad (RY)
Toronto Dominion Bk Ont Com New (TD)
Microsoft Corporation (MSFT)
Apple (AAPL)
Enbridge (ENB)
JPMorgan Chase & Co. (JPM)
Bank Of Montreal Cadcom (BMO)
Bk Nova Cad (BNS)
NVIDIA Corporation (NVDA)
Brookfield Corp Cl A Ltd Vt Sh (BN)
Cibc Cad (CM)
Tc Energy Corp (TRP)
Amazon (AMZN)
Fortis (FTS)
Spdr S&p 500 Etf Tr Tr Unit (SPY)

View all positions for TD Waterhouse Canada

Top funds holding Black Diamond Therapeutics

T. Rowe Price Investment Management
Vestal Point Capital
NEA Management Company
Vanguard Group
Tang Capital Management
Marshall Wace
Siren
BlackRock
Arrowstreet Capital, Limited Partnership
Millennium Management
UBS Group
AWM Investment Company
Renaissance Technologies
Geode Capital Management
Northern Trust

View all funds holding Black Diamond Therapeutics